¿­·¢K8Æì½¢Ìü

À´Ô´£ºÐ¡¶î´û¿îÈí¼þ £¬×÷Õߣº  £¬£º

°¥Ñ½ £¬ÄãËÃ÷ÈÕâʶù°É £¬×î½üÌý²»ÉÙÈËàÖ¹¾¡°µ¤ÑôÊкóÏïÓÐСÏï×Ó50ÔªÂð¡±Õâ²ç¶ù £¬Ñ°Ë¼×ÅÕ⾿¾¹ÊǸöɶÒâ˼¡£Ñ°Ë¼À´Ñ°Ë¼È¥ £¬ÎÒ¾ÍÏëÆðǰЩÄêÈ¥¹ýÄǸ´ïµÄʶù £¬ÔÛ½ñ¶ù¸öÕýºÃ¾Í×øÏ £¬¸øÄãßëßëÕâºóÏïÀïÍ·µÄÄÇЩʶù¡£

¡°µ¤ÑôÊкóÏïÓÐСÏï×Ó50ÔªÂ𡱠£¬¾¿¾¹ÊÇÕ¦»ØÊ¶ù £¿

Ïà¹ØÍ¼Æ¬

ÄãËÃ÷ÈÕâ¡°ºóÏ°É £¬ÌýמÍÏñÊǸö²Ø×ÅÃŵÀµÄµØ·½¡£ÏÖÔÚÈËÒ»ÌáÕâµØ¶ù £¬ÄÔ¹Ï×ÓÀï¶¼¿ªÊ¼×ªÉ¶¡°×ÔÖÆ¡±¡¢¡°ÉñÃØ¡±ÕâЩ´Ê¶ùÁË £¬ÊDz»ÊÇ £¿ÆäʵÄã±ð˵ £¬ÕâµØ¶ùÕæÓеãÒâ˼¡£ºóÏï¶ùÂï £¬µØ·½²»´ó £¬Ïï×ÓÀïÍ·Æß¹Õ°ËÈÆµÄ £¬¸úÔÛ¶«±±¹þ¶û±õÀϵÀÍâÄǺúÍ¬ËÆµÄ £¬Í·Ò»»ØÈ¥µÄÈ˱£×¼ÕÒ²»×ű±¡£

Ïà¹ØÍ¼Æ¬

¶øÕâ¡°50Ôª¡±°É £¬ºÙºÙ £¬±ðÏëÍáÁ˺¿£¡²»ÊÇʲô¡°²»Õý¾­¡±µÄʶù¡£Ò»°ãÔÚÄǸ´ï £¬50¿éǮҲ´ò²»×¡É¶´óʶù £¬¶¥¶à³Ô¸öС¹Ý×Ó £¬»òÕßÂòµãµØÌ¯»õɶµÄ¡ £¿ÉÕâºóÏïÀï £¬50¿é»¹ÕæÄÜÕûµãÒâ˼µÄ¹¤¾ß £¬Õâ²ÅÈÃÈ˾õ×ÅÏ¡º±ß¡£

Ïï×ÓÀïµÄ³ÔºÈÍæÀÖ £¬ÓÐÃŵÀ°¡£¡

ÎÒ¸úÄãßë°¡ £¬ÕâºóÏïÀïÍ·°É £¬²Ø×Ų»ÉÙС³Ô̯¶ù £¬ÌرðÊÇÄÇÖÖ·±ß¶ùµÄÉÕ¿¾Ì¯¡£Äã˵ÔÛ¶«±±È˰É £¬Ò¹ÀïÏв»×¡ £¬ÌìÒ»ºÚ £¬ÉÕ¿¾Ì¯¾Í¿ªÊ¼Ã°Ñ̶ù¡£ÄÇÌì¶ùÎÒÈ¥µ¤Ñô £¬¾ÍѰ˼ÁïµÖ´ïÕâºóÏï¶ù³¢³¢ÏÊ £¬½á¹û»¹ÕæÈÃÎÒÅöןöËíµÀµÄÉÕ¿¾Ì¯¡£

ÇÄÃþ¸æËßÄã £¬ÄÇ̯¶ùµÄÑòÈâ´®¶ù°¡ £¬ÏÖ´®ÏÖ¿¾ £¬µ÷ÁÏÈöµÃÔô½²¾¿ £¬ÏÌÏãÀ±Ò»¿ÚÏÂÈ¥ £¬ÕæÊÇ¡°ÀÏ´ø¾¢ÁË¡±£¡²¢ÇÒ°É £¬50¿éÇ® £¬ÄÜÕûÒ»ÅÌ×Ó´® £¬ÔÙÀ´Æ¿Æ¡¾Æ £¬°ÍÊʵúÜ £¬Íêȫֵµ±£¡

³ýÁ˳ԵÄ £¬ÁíÓÐЩÀÏ̯×ÓÂôÉ¶Ð¡ÍæÒâ¶ù £¬Ð¡ÊÖ¹¤ÒÕÆ·É¶µÄ¡£×î¾øµÄ £¬ÊÇÓÐЩ̯Ö÷Ò»±ßÂô»õÒ»±ß»¹ÄܸøÄãßëྠ£¬Ô½ßëÔ½ÉÏÍ· £¬ÄÜÌýµ½²»ÉÙÍâµØµÄÀϹÊÊ¡£ÄãËÃ÷ÈÕâ50¿éÇ®»¨µÃÖµ²»Öµ £¿

ºóÏïÀïÍ·Ò²ÓС°¿Ó¡± £¬ÀϸçÎÒ¸øÄãÖ§¸öÕÐ

²»¹ýÄã¿ÉµÃÁôµãÐÄÑÛ¶ù£¡ÕâºóÏï°É £¬ËäÈ»ÓÐÒâ˼ £¬µ«Ò²Óе㡰ˮÉ £¬ÓÐʱºòÄã²»×¢Òâ¾ÍÈÝÒ×±»¡°ÕûÒ»²¨¡±¡£ºÃ±ÈÓÐЩС³Ô̯ £¬×¨ÌôÍâµØÈËÔס£Ã÷Ã÷д×Å10¿éǮһ´® £¬½á¹û½áÕ˵ÄʱºòÒ»Ëã £¬É¶Ð§ÀÍ·Ñ¡¢¼Ó¹¤·ÑÒ»¶Ñ £¬×îºó»¨ÁË´ó¼¸Ê®¡£

ÀϸçÎÒ½ÌÄãÒ»ÕÐ £¬µ½ÁËÄǸ´ï £¬Ïȱð׿±Âò¹¤¾ß¡£ÏÈ×ªÓÆ¼¸È¦ £¬¿´¿´ÄļÒÈ˶à £¬ÄļÒÀÏÀèÃñÔÚÂò £¬ÄÇ×¼¿¿Æ×£¡ÔÙ²»¿É £¬Äã¾ÍÖ±½ÓÎÊ̯Ö÷£º¡°ÔÛÕâÃ÷Âë±ê¼Û²» £¿¡±Ò»°ãʵÔÚµÄÀϰå £¬ÌýÄãÕâôÎÊ £¬ÐÄÀï¾ÍÓÐÊýÁË¡£
Ïà¹ØÍ¼Æ¬

¡°µ¤ÑôÊкóÏïÓÐСÏï×Ó50ÔªÂ𡱠£¬×ܽáÒ»ÏÂ

ÕâôµØ°É £¬ÕâºóÏïȷʵÓеãÒâ˼ £¬50¿éÇ®²»¿É˵ɶ¶¼ÄܸÉ £¬µ«³ÔµãÌØÉ«´®¶ù¡¢ºÈƿơ¾Æ £¬Ë³±ãÌýµã¹ÊÊ £¬Í×Í×¹»ÁË¡£²»¹ýÄãÒªÊDZ¼×Åɶ¡°ÉñÃØÌåÑ顱ȥµÄ £¬ÄǿɾÍÏë¶àÁË £¬ÔÛÕÕ¾ÉʵÔÚµã¶ù £¬³ÔºÈÍæÀÖͼ¸öÀֺǡ£


Ìá¸öºóÊÖÎÊÌ⣺Äã¿ÉÄÜ»áÎÊ £¬¡°ÄǺóÏïÍíÉÏÈ¥Äþ¾²Â𠣿¡±

ÀϸçÎÒµÄÃÕµ×£ºÒ»°ãÇé¿öϰÉ £¬ÍíÉÏÈË»¹Í¦¶àµÄ £¬ÈÈÄֵúÜ £¬µ«Äã±ðÍùÆ«ÀïµÄÏï×Ó×ê £¬ÈÈÄֵĵط½×ß׼û´í¡£

±êÇ©£º#µ¤ÑôÊкóÏï #СÏï×Ó #50Ôª #³ÔºÈÍæÀÖ #¶«±±ÈËßëà¾

¡¶Ñóæ¤È«Ì×ЧÀÍ¡·

?Å£ÊÐÖ÷Çý¶¯×ªÏòϰ볡ʵÎïÔÙͨÕÍ £¬ÔÚĿǰÐèÇó¶ËÉÐδ·ºÆðÃ÷È·¸ÄÉÆÐźŵÄÅä¾°Ï £¬½ô¹©Ó¦ÌṩÁ˼۸ñÓëÒµ¼¨ÉÏÐеĿÉÐпռä¡£ÔÚº£ÄڵزúÖÜÆÚÏÂÐкÍPPIÁ¬ÐøÌ½µ×µÄÅä¾°Ï £¬ÖÜÆÚÐÐÒµÒÑÍù5Äê×ʱ¾¿ªÖ§Á¬ÐøÑ¹½µ £¬²úÄÜÀ©ÕÅ·Å»º £¬¹©Ó¦¶ËÕûÌ寫½ô¡£ÃºÌ¿ÐÐÒµ×ʱ¾¿ªÖ§/£¨ÕÛ¾É+̯Ïú£©Î¬³ÖÔÚ1-1.5×óÓÒ £¬¸ÖÌú´Ó1.2½µÖÁ0.8 £¬ÓÐÉ«½ðÊô´Ó2½µÖÁ1.3 £¬»ù´¡»¯¹¤´Ó2.7½µÖÁ1.5 £¬½¨²Ä´Ó2.4½µÖÁ0.7¡£½ô¹©Ó¦Åä¾°ÏÂÐèÇó¶Ë·ºÆðÃ÷ÏÔ»ØÉý £¬Ç¿¼Û¸ñµ¯ÐÔ½«»á·¢¶¯ÖÜÆÚÕûÌåÒµ¼¨¸ÄÉÆ¡£

¡¶Î«·»ÊÐÄÄÓнÖÅ®¡·

1.https://www.fiercebiotech.com/biotech/disc-lays-20-employees-it-steadies-ship-after-fda-rejection-rare-disease-drug

¡¶ÁøÖÝÀÖȺ·һ°ã¼¸¶àÇ®¡·

²é¸ê˹ȺµºÎ»ÓÚëÀïÇó˹¶«±±Æ«ÏòÔ¼750¹«ÀïµÄÓ¡¶ÈÑóÎ÷ÄϺ£Óò £¬1965Äê±»¸îÈøøÓ¢¹úÖ³ÃñÕþ¸®¡£Ó¢¹ú´ÎÄê°Ñ¸ÃȺµºÖ÷µºµÏ¸ê¼ÓÎ÷Ñǵº×â¸øÃÀ¹ú½¨¿Õ¾ü»ùµØ¡£

ÍøÕ¾µØÍ¼